Global Wheat Protein Market

Protein expression is a process in which proteins are synthesized, modified, regulated, and controlled in living organisms according to the host cell. Protein expression in the context of protein research can now also refer to the application of lab procedures necessary for protein production. The main product types for protein expression are reagents, competent cells, expression vectors, services, and instruments. A reagent is a substance or compound that is added to a system in order to produce a chemical reaction or to determine whether or not a reaction occurred. The various forms of protein expression include yeast expression, mammalian expression, algae expression, insect expression, bacterial expression, and cell-free expression that are used for therapeutic, industrial, and research applications. The different end users involve pharmaceutical and biotechnology companies, academic research, and contract research organizations. The protein expression market research report is one of a series of new reports from The Business Research Company that provides protein expression market statistics, including protein expression industry global market size, regional shares, competitors with a protein expression market share, detailed protein expression market segments, market trends and opportunities, and any further data you may need to thrive in the protein expression industry. This protein expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global protein expression market will grow from $2.87 billion in 2022 to $3.19 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global protein expression market is expected to grow to $4.96 billion in 2027 at a CAGR of 11.6%. An increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. Hence the rising demand for biologics is driving the protein expression market. For instance, according to an article published by Chemistry World, analysts stated that the biologics market hold a market share of more than a quarter of the entire pharmaceutical market in 2020. The global biologics market is expected to grow at 14.7% during 2021-2023. Government regulations related to protein therapeutics and the production of biologics may hinder the protein expression market growth. Government regulations on biologics to undergo rigorous preclinical and clinical trials prior to regulatory approval, and time-consuming process for approval of biologics with regards to health and the safety of any individual are restraining the market growth. Marketing and distribution of biologics including insulin, hormones, therapeutic antibodies, and vaccines depends upon the successful completion of clinical trials, which is a long, expensive, and uncertain process. According to FDA, for an approval of new biologic, Under the regulations (21 CFR 314.81(b)(2)(vii) and 601.70, a clinical trial approval usually takes 10- 12 months where firms are required to submit a report annually on the status of clinical safety, clinical efficiency, clinical pharmacology, and nonclinical toxicology study. Companies in the industry are increasingly adopting Microfluidics technology to enhance protein expression tests in order to reduce the time, cost, labor, and increase in the accuracy and performance. The microfluidics technology effectively analyzes biological samples than the traditional (macroscale) instruments. Microfluidics technology is used to measure the expression of proteins on cells and optimizes the output to generate results regarding protein expression. Therapeutics-on-a-chip (TOC) uses microfluidic platform and is able to synthesize proteins in a point-of-care setting to reduce cost associated with storage and transportation of therapeutic proteins. For instance, companies such as MissionBio, NanoCellect Biomedical, RainDance Technologies and Sphere fluidics have implemented this technology in protein expression test. The Protein Expression market in the U.S. is governed by the Food and Drug Administration (FDA) which lays down a series of guidelines for the manufacturers and retailers of this industry. Within FDA, Centre for Drug Evaluation and research (CDER) regulates biological products under FDA 101 which includes gene therapy products and vaccines. These regulations ensure the quality, safety, and efficacy of biological therapeutics products, and speed up innovations that make these products safer, and effective. The US FDA announced a fast-track initiative to review its drugs and biologics policy to speed the availability of therapies to patients with serious conditions, orphan drugs for rare disease, while preserving the safety and efficacy standards. FDA also removed a rule (Section 610.21 of the FDA code) that specified minimal potency limits for certain antibodies and antigens. The European Medicines Agency has also introduced policies that include a provision to waive the scientific advice fee, which encourages more academic groups and small companies to propose candidates for biologics. Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs, Promega Corporation, Qiagen, Takara Bio, Merck KGaA, Genscript Biotech Corporation, Life Technologies Corporation, Sigma-Aldrich Corporation, Lucigen Corporation, Synthetic Genomics Inc., Becton, Dickinson & Company, Lonza Group Ltd., Accelagen Inc., Geneva Biotech, Viva Biotech, Becton, Dickinson & Company, Sengenics, ARTES Biotechnology GmbH, Addgene Inc., Profacgen, ProteoGenix, Peak Proteins Ltd., Domainex Ltd., Jena Bioscience GmbH, EMD Millipore, and Oxford Expression Technologies Ltd. North America was the largest region in the protein expression market in 2022. Western Europe was the second largest region in the global protein expression market. The regions covered in the global protein expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the protein expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The protein expression market includes revenue earned by instruments, expression kits, and systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein expression market is segmented - 1) By Protein Expression: Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression 2) By End Use: Pharmaceutical And Biotechnological Companies, Academic Research, Contract Research Organizations 3) By Product: Reagents, Competent Cells, Expression vectors, Services, Instruments 4) By Application: Therapeutic, Industrial, Research

Protein labelling refers to the process of detecting or purifying the labelled protein and its binding partners by using the proper molecular labels. Most biological research uses one of three basic categories of protein labels: biotin, enzyme conjugates, or fluorescence probes. The main types of products in protein labelling are reagents, proteins, enzymes, probes or tags, and monoclonal antibodies. Monoclonal antibodies are created by cloning a single white blood cell. Every subsequent antibody generated in this manner may be traced back to a single parent cell. The different labelling methods include in-vitro labeling, and in-vivo labelling and are used in cell-based assays, fluorescence microscopy, immunological techniques, mass spectrometry, and protein microassays. The protein labelling market research report is one of a series of new reports from The Business Research Company that provides protein labelling market statistics, including the industry's global market size, regional shares, competitors with a protein labelling market share, detailed protein labelling market segments, market trends and opportunities, and any further data you may need to thrive in the protein labelling industry. This protein labelling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global protein labelling market grew from $2.13 billion in 2022 to $2.35 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The protein labelling market is expected to grow from $3.49 billion in 2027 at a CAGR of 10.4%. Increased spending on the R&D of proteomics and genomics is driving the growth of the protein labelling reagents market. Proteomics is the study of the overall protein content of a cell, tissue, or organism. Protein labelling methods before separation and analysis are essential during proteomic profiling approaches. For instance, the National Institutes of Health (NIH) of the United States, funded $37 billion for biomedical research. This funding is for life sciences research that supports study at a molecular level for the understanding of fundamental processes by which diseases develop, the identification of biomarkers that signal the presence of disease, or identification of genes or proteins responsible for the disease. The Novo Nordisk Foundation granted a grant of up to $1.5 million to the University of Copenhagen to establish a mass spectrometry facility, which marks a new and exciting step in protein research. Therefore, the increased spending on research and development of proteomics and genomics is driving the market. Drawbacks related to protein labelling techniques are expected to hinder the market. Label-free techniques are preferred over labelled techniques because of the drawbacks associated with them, such as wet-lab complexity and flexibility. While label-free samples can be measured without much preparation, wet lab pre-treatment is required for all labelling techniques. Samples must be labelled with metabolic (e.g. SILAC) or chemical (e.g. iTRAQ or TMT) reagents and the different conditions has to be combined. Therefore, label-free techniques are less prone to wet lab errors than labelling techniques. Label-free approaches have the advantage of being highly adaptable, even after the study has begun. New samples can be included at any time, but labelled approaches require the same number (n) of each condition. New samples may not be included in the study if they cannot be physically mixed and measured with the control. Labeled techniques such as the Super-SILAC approach reduce this problem but must also be carefully planned. These disadvantages are making label-free techniques preferable. Therefore, drawbacks associated with protein labeling techniques are expected to hinder the market. Companies in the protein labelling market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated as well as academic and research institutions in this market by way of partnerships, in or out-licensing deals, this trend has been increasing over recent years. For instance, recombinant protein manufacturer enGenes Biotech GmbH (enGenes) announced a collaboration with ACIB GmbH for protein labeling. In January 2020, Abcam, a UK-based protein research tools producer and seller, announced its decision to acquire Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences. Expedeon technology supports a diverse set of labels, including enzymes, metals, oligos, and fluorescent proteins. Abcam will combine the newly acquired capture and conjugation technologies with its extensive antibody and protein expertise to expand and enhance its portfolio of off-the-shelf, and custom reagents and tools. Expedeon is a Germany-based manufacturer of protein discovery and analysis products used for protein and drug research. Major players in the protein labelling market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer, Inc., General Electric Company, F. Hoffmann-La Roche AG, AGILENT TECHNOLOGIES INC., BIO-RAD LABORATORIES, Kirkegaard & Perry Laboratories, LI-COR Inc. and Kaneka Corporation. North America was the largest region in the protein labeling market in 2022. The regions covered in the global protein labelling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein labelling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The protein labeling market includes revenues earned by entities by detecting or purifying the labelled protein and its binding partners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global protein labelling market is segmented - 1) By Product: Reagents, Protein, Enzymes, Probes/ Tags, Monoclonal Antibodies 2) By Labeling Method: In-vitro Labeling, In-vivo Labeling 3) By Application: Cell Based-Assay, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Micro Assay

Malted wheat flour refers to flour manufactured from wheat grains that have been thoroughly germinated, cleaned, and processed into flour under controlled conditions. Malted wheat flour is used primarily in bread manufacturing and food applications. The malted wheat flour is used in bread to improve the texture of the soft part.     The main types of malted wheat flour are diastatic malted wheat flour and non-diastatic malted wheat flour. Diastatic malted wheat flour refers to a grain that has been sprouted, dried, and pounded into a powder, commonly wheat. Diastatic is used by bread bakers to ensure a high rise, excellent texture, and a nice brown crust.  The applications of malted wheat flour include food and beverage, bakery and confectionery, the nutrition industry, and other applications. The malted wheat flour market research report is one of a series of new reports from The Business Research Company that provides Malted wheat flour market statistics, including malted wheat flour industry global market size, regional shares, competitors with a malted wheat flour market share, detailed malted wheat flour market segments, market trends and opportunities, and any further data you may need to thrive in the malted wheat flour industry. This malted wheat flour market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global malted wheat flour market size grew from $35.88 billion in 2022 to $38.29 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The malted wheat flour market size is expected to grow to $46.8 billion in 2027 at a CAGR of 5.1%. An increase in consumer spending on bakery and confectionery items is expected to propel the growth of the malted wheat flour market going forward. Bakery refers to flour-based foods baked in an oven, whereas confectionery refers to sugar-based foods and desserts. Malted wheat flour is used primarily in bread manufacturing and other food applications. For instance, in June 2020, ConfectioneryNews, a France-based blog on the confectionery and biscuit industry, had approximately a 23% increase in consumer spending on confectionery items as compared to the previous years. Therefore, an increase in consumer spending on bakery and confectionery items is expected to boost demand for malted wheat flour during the forecast period. Product development with new formulations is a key trend gaining popularity in the malted wheat flour market. Major companies operating in the market are introducing new formulations and combinations of ingredients such as dextrose, barley flour, and enzymes to sustain their position in the market. For instance, in February 2021, Malt Products launched Diastatic Malt Flours, which are made from a combination of malted barley flour, wheat flour, and dextrose. Diastatic Malt Flour is a type of malted wheat flour that encourages a strong rise, great texture, and a brown crust in baked goods. It is a sweet, light-coloured powder designed for use in all types of yeast-raised doughs. In December 2021, Invivo Grou, a France-based agriculture cooperative group for milling and malt production acquired Soufflet Group for an undisclosed amount. This acquisition aims to a address the economic, social, and ecological difficulties faced in France's agriculture sector by strengthening its position in agriculture and food transition by expanding the use of its solution. Soufflet Group is a France-based agriculture food group. Major players in the malted wheat flour market are Malteurop Groupe S.A., Crisp Malting Group, Cargill, Inc., King Arthur Flour Company, Munton’s Plc, Simpsons Malt Ltd., Imperial Malts Ltd., IREKS Gmb, Archer-Daniels-Midland Company, Viking Malt, Muntons PLC, Malteurop Malting Co., and Graincorp Malt. Western Europe was the largest region in the malted wheat flour market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malted wheat flour market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the malted wheat flour market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The malted wheat flour market consists of sales of crunchy cereals, biscuits, coated cereals, functional flours, premixes, bakery improvers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global malted wheat flour market is segmented - 1) By Product Type: Diastatic Malted Wheat Flour, Non-Diastatic Malted Wheat Flour 2) By Application: Food And Beverage, Bakery And Confectionery, Nutrition Industry, Other Applications

Grain farming refers to growing grain crops and grain seeds to harvest their seeds at the end of the growing season. The main types of grain farming are dry pea and bean farming, wheat farming, and other types. Wheat farming refers to a cereal crop that is grown for food. The farming processes are organic grain farming and traditional farming. The various applications included food and beverages, fodder, and other applications. The grain farming market research report is one of a series of new reports from The Business Research Company that provides grain farming market statistics, including global market size, regional shares, competitors with a grain farming market share, detailed grain farming market segments, market trends and opportunities, and any further data you may need to thrive in the grain farming industry. This grain farming market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global grain farming market grew from $1,330.28 billion in 2022 to $1,456.66 billion in 2023 at a compound annual growth rate (CAGR) of 9.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The grain farming market is expected to grow to $2,113.54 billion in 2027 at a CAGR of 9.8%. Many chemical companies are offering bio-pesticides to control pests, insects, and weeds in farmlands. Biological organisms are often called antagonists. They include predators, parasitoids, and pathogens. Farmers are using it as an alternative to control pests as it does not cause damage to the crop or plant. Biopesticides are becoming increasingly popular and are safer than traditional chemical pesticides. Biopesticides are derived from natural materials such as animals, plants, bacteria, and certain minerals. When compared to chemical pesticides, biopesticides are inherently less harmful and are more target-specific than chemical pesticides. Major companies in the grain farming market include Cargill Incorporated, Bunge Limited, Bayer AG, Corteva Inc., UPL Limited, Seaboard Corporation, Syngenta AG, Nutrien Ltd., KWS Saat SE, Vilmorin & Cie SA. Asia-Pacific was the largest region in the grain farming market in 2022. North America was the second-largest region in the grain farming market. The regions covered in the grain farming market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the grain farming market are Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Iran, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, Ukraine, USA, and Vietnam. The grain farming market consists of revenues earned by entities that produce grain crops and grain seeds of wheat, barley, oats, corn, rice, and other grains. These crops are typically grown in open fields and have an annual growth cycle. This market excludes processed grain products such as flour and other products. This market also excludes the proceeds from the captive (internal) consumption of the grains for further processing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global grain farming market is segmented - 1) By Type: Dry Pea And Bean Farming, Wheat Farming, Other Grain Farming 2) By Application: Food & Beverages, Fodder, Other Applications 3) By Farming Process: Organic Grain Farming, Traditional Farming

Grain farming refers to growing grain crops and grain seeds to harvest their seeds at the end of the growing season. The main types of grain farming are dry pea and bean farming, wheat farming, and other types. Wheat farming refers to a cereal crop that is grown for food. The farming processes are organic grain farming and traditional farming. The various applications included food and beverages, fodder, and other applications. The grain farming market research report is one of a series of new reports from The Business Research Company that provides grain farming market statistics, including global market size, regional shares, competitors with a grain farming market share, detailed grain farming market segments, market trends and opportunities, and any further data you may need to thrive in the grain farming industry. This grain farming market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global grain farming market grew from $1,330.28 billion in 2022 to $1,456.66 billion in 2023 at a compound annual growth rate (CAGR) of 9.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The grain farming market is expected to grow to $2,113.54 billion in 2027 at a CAGR of 9.8%. Many chemical companies are offering bio-pesticides to control pests, insects, and weeds in farmlands. Biological organisms are often called antagonists. They include predators, parasitoids, and pathogens. Farmers are using it as an alternative to control pests as it does not cause damage to the crop or plant. Biopesticides are becoming increasingly popular and are safer than traditional chemical pesticides. Biopesticides are derived from natural materials such as animals, plants, bacteria, and certain minerals. When compared to chemical pesticides, biopesticides are inherently less harmful and are more target-specific than chemical pesticides. Major companies in the grain farming market include Cargill Incorporated, Bunge Limited, Bayer AG, Corteva Inc., UPL Limited, Seaboard Corporation, Syngenta AG, Nutrien Ltd., KWS Saat SE, Vilmorin & Cie SA. Asia-Pacific was the largest region in the grain farming market in 2022. North America was the second-largest region in the grain farming market. The regions covered in the grain farming market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the grain farming market are Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Iran, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, Ukraine, USA, and Vietnam. The grain farming market consists of revenues earned by entities that produce grain crops and grain seeds of wheat, barley, oats, corn, rice, and other grains. These crops are typically grown in open fields and have an annual growth cycle. This market excludes processed grain products such as flour and other products. This market also excludes the proceeds from the captive (internal) consumption of the grains for further processing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global grain farming market is segmented - 1) By Type: Dry Pea And Bean Farming, Wheat Farming, Other Grain Farming 2) By Application: Food & Beverages, Fodder, Other Applications 3) By Farming Process: Organic Grain Farming, Traditional Farming

Vegan foods are foods that are produced without the use of animal ingredients or animal-derived ingredients. The vegan food research report is one of a series of new reports from The Business Research Company that provides vegan food statistics, including global market size, regional shares, competitors with vegan food share, detailed vegan food segments, market trends and opportunities, and any further data you may need to thrive in the vegan food industry. This vegan food research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global vegan food market size will grow from $16.05 billion in 2022 to $18.27 billion in 2023 at a compound annual growth rate (CAGR) of 13.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global vegan food market size is expected to grow from $29.19 billion in 2027 at a CAGR of 12.4%. An increase in concern about the environment among the population is driving the growth of the vegan market. Rearing and breeding livestock such as pigs, hens, cows, and goats on farms contributes to the greenhouse effect. Greenhouse gases are released from the agriculture of livestock such as cows, and the gases are released to block the atmospheric heat from escaping, which increases the overall temperature. The demand for animal meat requires the excess practice of animal farming. Thus, an increase in the number of consumers of vegan food eliminates the demand for excessive animal farming, following a decrease in greenhouse gas emissions in the environment. According to the United States Environmental Protection Agency, a US-based independent executive agency for the environment, in 2020, total greenhouse gas emissions were 5,981 million metric tons of carbon dioxide equivalent. Thus, an increase in concern about the environment among the population is driving the growth of the vegan market. Certain vegan food products lack certain nutrients. Vegan products do not contain any animal ingredients or animal-derived ingredients. Vegan food doesn't contain an adequate amount of high-quality protein and fats. Both vegan and vegetarian diets lack many very important minerals, such as calcium, iron, and zinc. According to a study published in 2020 by BMC Medicine, vegans have a higher fracture risk as compared to meat-eaters, fish-eaters, and vegetarians. The strongest associations were observed for hip fractures, for which fish eaters, vegetarians, and vegans all had higher risks. This is due to an inadequate calcium intake in a vegan diet. Therefore, the lack of essential nutrients impacts the growth of the vegan market. One of the trends in the vegan market is the production of meat through cell-based technology. The cell-by-cell identical meat is produced in factories without involving the killing of animals. Production of cell-based meat involves feeding the animal cells with nutrients and proteins, thus eliminating the need for dependence on animals for meat. For instance, in October 2022, a US-based pet food manufacturer introduced the cellular-based meat broth topper for dogs known as chicken broth topper, which will replace factory-framed products with cruelty-free cell-based meet to challenges related to the low quality and contamination of pet food. Other major players such as Tyson Foods., an U.S.A. based processor and marketer of chicken, beef, and pork, are also investing in Memphis Meats in order to support the cell -based meat production. Major players in the market are Amy's Kitchen, Vitasoy International Holdings Ltd., Beyond Meat, Tofutti Brands, Plamil Foods Ltd., Danone S.A., Vbites Foods Ltd., Eden Foods Inc., Whitewave Foods Company Inc., Sun Opta Inc. Asia-Pacific was the largest region in the vegan food market in 2022. Western Europe was the second-largest region in the global vegan food market. The regions covered in the global vegan food market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The vegan food market consists of sales of vegan fruits and vegetables, legumes such as vegan peas, vegan beans, plant protein-based tofu, and plant protein-based meat. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global vegan food market is segmented - 1) By Product Substitute: Dairy Alternative, Meat Substitute, Other Product Substitutes 2) By Distribution Channel: Online, Offline 3) By Source: Wheat, Soy, Oats, Almond, Other Sources

Organic grain farming refers to growing organic grain crops and grain seeds using organic farming, which reduces the use of toxins in the soil, such as diesel and fertilizer that may harm the earth or leach into water supplies. The main types of organic grain farming are organic corn, organic wheat, and other types. Organic corn is a non-GMO source of vitamin C and magnesium, as well as a significant source of dietary fiber. Pure organic farming and integrated organic farming are two types of farming that are used in the household, commercial, and other sectors. The organic grain farming market research report is one of a series of new reports from The Business Research Company that provides organic grain farming market statistics, including organic grain farming industry global market size, regional shares, competitors with an organic grain farming market share, detailed organic grain farming market segments, market trends and opportunities, and any further data you may need to thrive in the organic grain farming industry. This organic grain farming market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global organic grain farming market size will grow from $42.86 billion in 2022 to $46.55 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global organic grain farming market size is expected to grow to $65.07 billion in 2027 at a CAGR of 8.7%. The increasing preference of consumers for organic food products is a key factor driving the growth of the organic grain farming market. Enhanced performance and better quality of products have driven the growth of organic products in the last five years. For instance, according to the research institute of organic agriculture (FiBL) 2020, globally, there are more than 70 million hectares of organic farmland. Also, the rising demand has motivated manufacturers to make organic food more accessible to mainstream markets. For example, Woolworths and Coles supermarkets in Australia now sell a broader variety of organic produce, making it more convenient to purchase organic goods. The risks associated with the high cost of transition and uncertain market guarantees at the end of the transition period are a key factor hampering the growth of the organic grain farming market. The transition time for a farmer to switch to organic grain production is 36 months from the last prohibited product being used. In the transition period, the farmer pays all the organic production costs but sells them to the traditional markets as they cannot be sold organically. So, the farmer may lose around $208,705 each year, with a cumulative deficit of $417,000 by year two. The farmer can market grains for organic rates in the third year to a profit of $843,000, but it needs $417,000 in working capital to get out of years one and two. Therefore, the risks associated with the high cost of transition and the uncertain market guarantee at the end of the transition period are expected to hinder the growth of the organic grain farming market. The internet of things (IoT)-enabled smart farming is a key trend in the organic grain farming market. IoT-enabled devices and sensors are installed in the field, and farmers can easily access this data via tablets and cell phones. For example, in January 2021, according to an article published by YourStory, a India based startup magazine, "numerous horticulture farmers can now manage their crops profitably and remotely thanks to the precision agricultural firm Fasal, which utilizes AI, IoT, and analytics to take the guesswork out of farming. IoT is used by agtech firm Fasal to enable remote horticulture farming. In July 2022, Albert Lea Seed House, a US based company specializing in non-GMO and organic seed, acquired Blue River Organic Seed for an undisclosed amount. Through this acquisition, Albert Lea Seed offers the greatest genetics specifically suited to organic farming, supplied by a team with a farmer focus and expertise in organic farming and from a family-owned business dedicated to the long-term expansion and success of organic farming. Blue River Organic Seed is a US-based organic seed production company specializing in organic corn, silage, soybean, alfalfa, forages, and sorghum seeds. Major players in the organic grain farming market are Marroquin Organic International, Organic Partners International, Briess Malt and Ingredients Co., St. Charles Trading, International Sugars, Tate and Lyle, Ingredion Incorporated, Cargill, Roquette America, and Royal Ingredients Group. North America was the largest region in the organic grain farming market in 2022. South America was the second largest region in the global organic grain farming market. The regions covered in the global organic grain farming market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the organic grain farming market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The organic grain farming market consists of revenues earned by entities that produce organic corn, organic wheat, and other organic grain farming. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global organic grain farming market is segmented - 1) By Type: Organic Corn, Organic Wheat, Other Types 2) By End-User: Household, Commercial, Other End Users 3) By Farming Type: Pure Organic Farming, Integrated Organic

Protein inhibitors refer to compounds that interfere with the steps directly involved in the production of new proteins in cells. Protein inhibitors operate at the ribosome level, benefiting from the significant variations between prokaryotic and eukaryotic ribosome architectures. The main product types of protein inhibitors are protein kinase inhibitors, monoclonal antibodies, and others. Monoclonal antibodies are laboratory-created molecules designed to act as substitute antibodies, restoring, enhancing, modifying, or mimicking the immune system's attack on unwanted cells, such as cancer cells. The protein inhibitors are used in the treatment of oncology, inflammatory diseases, and others, and are distributed by hospital pharmacies, independent pharmacies, and online pharmacies. The protein inhibitors market research report is one of a series of new reports from The Business Research Company that provides protein inhibitors market statistics, including protein inhibitors industry global market size, regional shares, competitors with a protein inhibitors market share, detailed protein inhibitors market segments, market trends and opportunities, and any further data you may need to thrive in the protein inhibitors industry. This protein inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global protein inhibitors market grew from $68.17 billion in 2022 to $74.3 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The protein inhibitors market is expected to grow from $105.43 billion in 2027 at a CAGR of 9.1%. The increasing prevalence of chronic diseases is predicted to contribute to the growth of the protein inhibitors market over the forecast period. Chronic diseases such as cancer, cardiovascular diseases, and autoimmune diseases are becoming more prevalent. For instance, in May 2022, according to the World Health Organization, chronic diseases are expected to become the seventh leading cause of death globally by the end of 2030.In the USA, the number reached 157 million in 2020, with 87 million people having multiple conditions. Protein inhibitors are used for the treatment of these diseases attributing to fewer adverse effects and higher efficacy. Therefore, an increasing number of people with chronic diseases are anticipated to propel the demand for protein inhibitors market. The high cost of protein inhibitors used for cancer is anticipated to limit the growth of the protein inhibitors market shortly. Monoclonal antibodies are a type of protein made in the laboratory to bind substances in the body including cancer cells and are used to treat various types of cancer. Monoclonal antibody therapies are considered to be costlier when used for cancer. For instance, according to the National Center for Biotechnology Information, the average price of monoclonal antibodies was $96,731 for 34 monoclonal antibody indication combinations. Oncology and hematology monoclonal antibodies represented 40% of approved monoclonal antibody indication combinations, yet accounted for more than 85% of those priced at $100,000 or higher. The price of oncology or hematology monoclonal antibodies was $149,622 higher than those used in metabolic or cardiovascular disorders, $106,830 higher than in ophthalmology, $128,856 higher than in infectious diseases or allergies, and $98,981 higher than in immunology. Thus, the high cost of protein inhibitors including monoclonal antibodies for the treatment of cancer is expected to hinder the market’s growth. Companies in the protein inhibitors market are increasingly investing in various strategic initiatives such as partnerships and collaborations to develop new drugs to meet the market demand. Strategic collaborations and partnership agreements help companies to expand their existing product portfolio and geographical presence. For instance, in February 2020, Catalent, Inc., a USA-based provider of delivery technologies, drug manufacturing, gene therapies, biologics, and consumer healthcare products announced a partnership agreement with Zumutor Biologics Inc., an immune-oncology company based in the USA to manufacture ZM008, a monoclonal antibody targeting solid tumors. Moreover, in February 2021, Eli Lilly and Company, a USA-based pharmaceutical company, and Rigel Pharmaceuticals, Inc., a USA-based biotechnology company, announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for all indications, including autoimmune and inflammatory diseases. In June 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired ReViral for $525 million. The acquisition strengthens Pfizer's commitment to creating both medications and vaccines to help fight the respiratory syncytial virus while also expanding its anti-infective portfolio (RSV). ReViral is a UK-based clinical-stage biopharmaceutical company pioneering in the discovery and development of innovative antiviral drugs for disorders brought on by the respiratory syncytial virus. Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, GlaxoSmithKline, Pfizer, Boehringer Ingelheim, and F. Hoffmann-La Roche. North America was the largest region in the protein inhibitors market in 2022. The regions covered in the global protein inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the global protein inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The protein inhibitors market consists of sales of erythromycin, tetracycline, chloramphenicol, and aminoglycosides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein inhibitors market is segmented - 1)By Product: Protein Kinase Inhibitors, Monoclonal Antibody, Other Products 2)By Application: Oncology, Inflamatory Diseases, Other Applications 3)By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies